181 related articles for article (PubMed ID: 22563505)
1. Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.
van Rikxoort M; Michaelis M; Wolschek M; Muster T; Egorov A; Seipelt J; Doerr HW; Cinatl J
PLoS One; 2012; 7(5):e36506. PubMed ID: 22563505
[TBL] [Abstract][Full Text] [Related]
2. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
[TBL] [Abstract][Full Text] [Related]
3. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
J Virol; 2012 Nov; 86(22):12341-50. PubMed ID: 22951840
[TBL] [Abstract][Full Text] [Related]
5. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.
Penghui Y; Fang S; Ruilan W; Guanglin L; Hongjing G; Yueqiang D; Zhongpeng Z; Xiaolan Y; Zhaohai W; Shaogeng Z; Xiliang W
Hum Gene Ther; 2019 Mar; 30(3):330-338. PubMed ID: 30205709
[TBL] [Abstract][Full Text] [Related]
7. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
8. Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.
Yu H; Sun F; Xu Y; Yang H; Tian C; Li C; Kang Y; Hao L; Yang P
Hum Gene Ther; 2024 Mar; 35(5-6):177-191. PubMed ID: 38386514
[TBL] [Abstract][Full Text] [Related]
9. Requirement for ERK activation in cisplatin-induced apoptosis.
Wang X; Martindale JL; Holbrook NJ
J Biol Chem; 2000 Dec; 275(50):39435-43. PubMed ID: 10993883
[TBL] [Abstract][Full Text] [Related]
10. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
[TBL] [Abstract][Full Text] [Related]
11. Endogenous expression of proteases in colon cancer cells facilitate influenza A viruses mediated oncolysis.
Sturlan S; Stremitzer S; Bauman S; Sachet M; Wolschek M; Ruthsatz T; Egorov A; Bergmann M
Cancer Biol Ther; 2010 Sep; 10(6):592-9. PubMed ID: 20647775
[TBL] [Abstract][Full Text] [Related]
12. Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells.
Efferson CL; Tsuda N; Kawano K; Nistal-Villán E; Sellappan S; Yu D; Murray JL; García-Sastre A; Ioannides CG
J Virol; 2006 Jan; 80(1):383-94. PubMed ID: 16352563
[TBL] [Abstract][Full Text] [Related]
13. NS1 protein of influenza A virus down-regulates apoptosis.
Zhirnov OP; Konakova TE; Wolff T; Klenk HD
J Virol; 2002 Feb; 76(4):1617-25. PubMed ID: 11799156
[TBL] [Abstract][Full Text] [Related]
14. Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.
Gaston DC; Odom CI; Li L; Markert JM; Roth JC; Cassady KA; Whitley RJ; Parker JN
PLoS One; 2013; 8(11):e81768. PubMed ID: 24312353
[TBL] [Abstract][Full Text] [Related]
15. RuvB-Like Protein 2 Interacts with the NS1 Protein of Influenza A Virus and Affects Apoptosis That Is Counterbalanced by Type I Interferons.
Wang Y; Zhou J; Mackintosh SG; Du Y
Viruses; 2021 May; 13(6):. PubMed ID: 34072766
[TBL] [Abstract][Full Text] [Related]
16. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.
Wang X; Li M; Zheng H; Muster T; Palese P; Beg AA; García-Sastre A
J Virol; 2000 Dec; 74(24):11566-73. PubMed ID: 11090154
[TBL] [Abstract][Full Text] [Related]
17. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
[TBL] [Abstract][Full Text] [Related]
18. Effect of human activated NRAS on replication of delNS1 H5N1 influenza virus in MDCK cells.
Zhu J; Zhou H; Zou W; Jin M
Virol J; 2011 May; 8():240. PubMed ID: 21595878
[TBL] [Abstract][Full Text] [Related]
19. Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1.
Wood LW; Shillitoe EJ
Cancer Gene Ther; 2011 Oct; 18(10):685-94. PubMed ID: 21701533
[TBL] [Abstract][Full Text] [Related]
20. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis.
Salvatore M; Basler CF; Parisien JP; Horvath CM; Bourmakina S; Zheng H; Muster T; Palese P; García-Sastre A
J Virol; 2002 Feb; 76(3):1206-12. PubMed ID: 11773396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
